Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Integra LifeSciences Holdings Corporation (IART) had Free Cash Flow per Share of $-0.07 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$391.92M |
|
$-4.62M |
|
$174.94M |
|
$216.98M |
|
$380.45M |
|
$11.47M |
|
$-13.88M |
|
$-2.41M |
|
$-2.41M |
|
$-4.62M |
|
$-4.62M |
|
$-4.62M |
|
$-4.62M |
|
$11.47M |
|
$50.90M |
|
76.95M |
|
76.95M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$1.17B |
|
$446.88M |
|
$2.41B |
|
$3.58B |
|
$346.85M |
|
$1.83B |
|
$2.19B |
|
$2.54B |
|
$1.04B |
|
$-676.19M |
|
$1.04B |
|
77.82M |
|
| Cash Flow Statement Financials | |
$9.80M |
|
$-14.85M |
|
$8.30M |
|
$235.05M |
|
$236.81M |
|
$1.76M |
|
$5.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.38 |
|
-- |
|
-- |
|
0.64 |
|
1.79 |
|
55.36% |
|
2.93% |
|
2.93% |
|
-- |
|
-0.61% |
|
-1.18% |
|
$-5.04M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.35 |
|
1.48 |
|
60.72 |
|
-0.44% |
|
0.68% |
|
-0.13% |
|
-0.16% |
|
$13.40 |
|
|
Free Cash Flow per Share |
$-0.07 |
$0.13 |
|